Cargando…
Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan
The objectives of this study are to assess the efficacy and safety of frovatriptan, and rizatriptan in the subgroup of women with menstrually related migraine of a multicenter, randomized, double blind, cross-over study. Each patient received frovatriptan 2.5 mg or rizatriptan 10 mg in a randomized...
Autores principales: | Savi, Lidia, Omboni, Stefano, Lisotto, Carlo, Zanchin, Giorgio, Ferrari, Michel D., Zava, Dario, Pinessi, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208043/ https://www.ncbi.nlm.nih.gov/pubmed/21842274 http://dx.doi.org/10.1007/s10194-011-0366-9 |
Ejemplares similares
-
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine
por: Savi, Lidia, et al.
Publicado: (2010) -
Frovatriptan and Rizatriptan Economic EVAluation: the FREEVA study
por: Lisotto, Carlo, et al.
Publicado: (2013) -
Efficacy of frovatriptan as compared to other triptans in migraine with aura
por: Evers, Stefan, et al.
Publicado: (2015) -
Frovatriptan vs almotriptan for treatment of menstrual migraine: a double-blind, randomized, cross-over, multicenter Italian study
por: Bartolini, M, et al.
Publicado: (2013) -
Suggested randomized, controlled trial for frovatriptan: a reply
por: Omboni, Stefano, et al.
Publicado: (2011)